Cargando…
Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases presc...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265319/ https://www.ncbi.nlm.nih.gov/pubmed/35805300 http://dx.doi.org/10.3390/ijerph19137632 |
_version_ | 1784743184116482048 |
---|---|
author | Sattler, Sebastian von dem Knesebeck, Olaf |
author_facet | Sattler, Sebastian von dem Knesebeck, Olaf |
author_sort | Sattler, Sebastian |
collection | PubMed |
description | This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases prescription drug misuse, especially if employees overcommit. To test these assumptions, we conducted a prospective study using a nationwide web-based sample of the working population in Germany (N = 11,197). Effort, reward, and overcommitment were measured at t(1) and the 12 month frequency of prescription drug misuse for enhancing cognitive performance was measured at a one-year follow-up (t(2)). The results show that 2.6% of the respondents engaged in such drug misuse, of which 22.7% reported frequent misuse. While we found no overall association between misuse frequency and effort, reward, or their imbalance, overcommitment was significantly associated with a higher misuse frequency. Moreover, at low levels of overcommitment, more effort and an effort–reward imbalance discouraged future prescription drug misuse, while higher overcommitment, more effort, and an imbalance increased it. These findings suggest that a stressful work environment is a risk factor for health-endangering behavior, and thereby underlines the importance of identifying groups at risk of misusing drugs. |
format | Online Article Text |
id | pubmed-9265319 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92653192022-07-09 Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany Sattler, Sebastian von dem Knesebeck, Olaf Int J Environ Res Public Health Article This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases prescription drug misuse, especially if employees overcommit. To test these assumptions, we conducted a prospective study using a nationwide web-based sample of the working population in Germany (N = 11,197). Effort, reward, and overcommitment were measured at t(1) and the 12 month frequency of prescription drug misuse for enhancing cognitive performance was measured at a one-year follow-up (t(2)). The results show that 2.6% of the respondents engaged in such drug misuse, of which 22.7% reported frequent misuse. While we found no overall association between misuse frequency and effort, reward, or their imbalance, overcommitment was significantly associated with a higher misuse frequency. Moreover, at low levels of overcommitment, more effort and an effort–reward imbalance discouraged future prescription drug misuse, while higher overcommitment, more effort, and an imbalance increased it. These findings suggest that a stressful work environment is a risk factor for health-endangering behavior, and thereby underlines the importance of identifying groups at risk of misusing drugs. MDPI 2022-06-22 /pmc/articles/PMC9265319/ /pubmed/35805300 http://dx.doi.org/10.3390/ijerph19137632 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Sattler, Sebastian von dem Knesebeck, Olaf Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title | Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title_full | Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title_fullStr | Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title_full_unstemmed | Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title_short | Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany |
title_sort | effort–reward imbalance at work and prescription drug misuse—prospective evidence from germany |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265319/ https://www.ncbi.nlm.nih.gov/pubmed/35805300 http://dx.doi.org/10.3390/ijerph19137632 |
work_keys_str_mv | AT sattlersebastian effortrewardimbalanceatworkandprescriptiondrugmisuseprospectiveevidencefromgermany AT vondemknesebeckolaf effortrewardimbalanceatworkandprescriptiondrugmisuseprospectiveevidencefromgermany |